Clinical Trial Update: Immunogenicity and Reactogenicity of Pneumococcal Polysaccharide and Conjugate Vaccines in Native Elders [Phase 1]

View source ↗

Summary

This Phase 1 trial reports immunogenicity and reactogenicity data for pneumococcal polysaccharide and conjugate vaccines in elderly participants, with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infections

Drugs mentioned

• Pneumococcal conjugate vaccine (PCV13) (Pneumococcal conjugate vaccine)
• Pneumococcal polysaccharide vaccine (PPSV23) (Pneumococcal polysaccharide vaccine)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Pneumococcal Infections | Phase 1 | Status: COMPLETED | Results posted: 2024-10-01